Protein transduction into the mouse otocyst using arginine-rich cell-penetrating peptides

NeuroReport

Volumn 22, Issue 18, 2011, Pages 994-999

  Miwa, Toru ^a   Minoda, Ryosei ^a   Kaitsuka, Taku ^b   Ise, Momoko ^a   Tomizawa, Kazuhito ^b   Yumoto, Eiji ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Cell penetrating peptides; otocyst; poly arginine; protein transduction

Indexed keywords

CELL PENETRATING PEPTIDE; ENHANCED GREEN FLUORESCENT PROTEIN; POLYARGININE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; EMBRYO; GENE TARGETING; HEARING; INNER EAR; INNER EAR DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; VESTIBULAR FUNCTION;

ANIMALS; CELL-PENETRATING PEPTIDES; EAR, INNER; EMBRYO, MAMMALIAN; EVENT-RELATED POTENTIALS, P300; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; GREEN FLUORESCENT PROTEINS; HAIR CELLS, AUDITORY, INNER; MICE; PREGNANCY; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 81855165011     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0b013e32834da8f8     Document Type: Article

References (24)

1. Bedrosian JC, Gratton MA, Brigande JV,Tang W, Landau J, Benette J. In-vivo delivery of recombinant viruses to the fetal murine cochlea: transduction characteristics and long-term effects on auditory function. Mol Ther 2006; 14:328-335. (Pubitemid 44184963)
2. Minoda R, Kawamoto K, Raphael Y. Trans-utero gene transfer into the mouse otocyst. Assoc Res Otolaryngol Abs 2003; 26:162-163.
3. Gubbels SP, Woessner DW, Mitchell JC, Ricci AJ, Brigande JV. Functional auditory hair cells produced in the mammalian cochlea by in utero gene transfer. Nature 2008; 455:537-541.
4. Green M, Loewenstein PM. Autonomous functional domains of chemically synthesized human immunodeficiency virus Tat trans-activator protein. Cell 1998; 55:1179-1188.
5. Frankel AD, Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988; 55:1189-1193. (Pubitemid 19020071)
6. Nagahara H, Vocero-Akbani AM, Snyder EL, Ho A, Latham DG, Lissy NA, et al. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p-27Kip1 induces cell migration. Nat Med 1998; 4:1449-1452. (Pubitemid 28553472)
7. Schmidt N, Mishra A, Lai GH, Wong GCL. Arginine-rich cell-penetrating peptides. FEBS Lett 2010; 584:1806-1813.
8. Schwarze SR, Ho A, Vocero-Akbani AM, Dowdy SF. In-vivo protein transduction: delivery of a biologically active protein into the mouse. Science 1999; 285:1569-1572. (Pubitemid 29420581)
9. Eguchi A, Meade BR, Chang YC, Fredrickson CT, Willert K, Nitin P, et al. Efficient si RNA delivery into primary cells by a peptide transduction domain-ds RNA binding domain fusion protein. Nat Biotechnol 2009; 27:567-571.
10. Takenobu T, Tomizawa K, Matsushita M, Li ST, Moriwaki A, Lu YF, et al. Development of p53 protein transduction therapy using membrane-permeable peptides and the application to oral cancer cells. Mol Cancer Ther2002; 1:1043-1049.
11. Futaki S. Membrane-permeable arginine-rich peptides and the translocation mechanisms. Adv Drug Deliv Rev 2005; 5:547-558. (Pubitemid 40255560)
12. Futaki S. Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. Int J Pharmaceut 2002; 245:1-7. (Pubitemid 35299886)
13. Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. PNAS 2000; 9:13003-13008.
14. Rothbard JB, Garlington S, Lin Q, Kirschberq T, Kreider E, Mc Grane PL, et al. Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation. Nat Med 2000; 6:1253-1257.
15. Lindsay MA. Peptide-mediated cell delivery: application in protein target validation. Curr Opin Pharmacol 2002; 2:587-594.
16. Matsushita M,Tomizawa K, Moriwaki A, Li ST,Terada H, Matsui H. High-efficiency protein transduction system demonstrating the role of PKA in long-lasting long-term potentiation. J Neuroscience 2001; 16:6000-6007. (Pubitemid 32737733)
17. Kawamoto K, Oh SH, Kanzaki S, Brown N, Raphael Y. The functional and structural outcome of inner ear gene transfer via the vestibular and cochlear fluids in mice. Mol Ther 2001; 4:575-585. (Pubitemid 34026873)
18. Hartman BH, Reh TA, Bermingham-Mc Donogh O. Notch signaling specifies prosensory domains via lateral induction in the developing mammalian inner ear. Proc Natl Acad Sci USA 2010; 107:15792-15797.
19. Matsushita M, Noguchi H, Lu YF, Tomizawa K, Michiue H, Li ST, et al. Photo-acceleration of protein release from endosome in the protein transduction system. FEBS Lett 2004; 572:221-226. (Pubitemid 39092539)
20. Michiue H, Tomizawa K, Wei FY, Matsushita M, Lu YF, Ichikawa T, et al. The NH2 terminus of influenza virus hemagglutinin-2 subunit peptides enhances the antitumor potency of polyarginine-mediated p53 protein transduction. J Biol Chem 2005; 280:8285-8289. (Pubitemid 40349730)
21. Araki D, Takayama K, Inoue M, Watanabe T, Kumon H, Futaki S, et al. Cell-penetrating D-isomer peptides of p53 C-terminus: long-term inhibitory effect on the growth of bladder cancer. Urology 2010; 75:813-819.
22. Laakkonen P, Akerman ME, Biliran H, Yang M, Ferrer F, Karpanen T, et al. Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells. Proc Natl Acad Sci USA 2004; 101:9381-9386. (Pubitemid 38812883)
23. Kemp BE, Cheng HC, Walsh DA. Peptide inhibitors of c AMP-dependent protein kinase. Methods Enzymol1988; 159:173-183.
24. Järver P, Mäger I, Langel U. In-vivo biodistribution and efficacy of peptide mediated delivery. Trends Pharmacol Sci 2010; 31:528-535.